Cytoplasmic chromatin fragments: Divergent roles in senescence and cancer
Ageing and Cancer Research & Treatment · 2024
DOI: 10.70401/acrt.2026.0016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ageing and Cancer Research & Treatment, 2024. Verfasst von Weifang Xiang und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Cytoplasmic chromatin fragments (CCFs) are structures formed by nuclear chromatin leaked into the cytoplasm in response to cellular senescence, stress, or tumorigenesis, primarily due to genomic instability and nuclear envelope rupture. These cytoplasmic DNA fragments are recognized by cyclic guanosine monophosphate–adenosine monophosphate synthase (cGAS) and activate the cGAS–STING pathway, which promotes activation of IRF3 and NF-κB, and induces expression of type I interferons and pro-inflammatory cytokines, thereby driving the senescence-associated secretory phenotype (SASP). CCFs are not only a hallmark of cellular senescence but also a critical signaling hub that links DNA damage to chronic inflammation via SASP factors like IL-6 and IL-8, reinforcing senescence through autocrine and paracrine loops. In cancer, CCFs play distinct roles at different stages: in early-stage tumors, they induce cell cycle arrest and enhance immune surveillance, thereby suppressing tumor initiation; whereas in advanced tumors, persistent CCFs chronically activate the cGAS–STING–NF-κB signaling axis, promoting epithelial–mesenchymal transition, angiogenesis, metastasis, and immune evasion. Notably, CCFs formation is heterogeneous and regulated by key factors such as p53, 53BP1, and Lamin B1. Therefore, targeting the CCFs–cGAS–STING pathway and its upstream regulators, including mitochondrial function, autophagy, and epigenetic modifications, offers a promising strategy to alleviate aging-related diseases and improve cancer therapy by suppressing SASP and blocking tumor progression. This review summarizes the mechanisms of CCFs biogenesis, their complex roles in aging and cancer, and emerging therapeutic approaches aimed at this axis, offering insights for both basic research and clinical translation.
Zitieren
APA
Xiang, W., Wang, S., Pan, Y., Cong, X., Lu, J., & Zhang, Y. (2024). Cytoplasmic chromatin fragments: Divergent roles in senescence and cancer. Ageing and Cancer Research & Treatment. https://doi.org/10.70401/acrt.2026.0016
Vancouver
Xiang W, Wang S, Pan Y, Cong X, Lu J, Zhang Y. Cytoplasmic chromatin fragments: Divergent roles in senescence and cancer. Ageing and Cancer Research & Treatment. 2024. doi:10.70401/acrt.2026.0016
BibTeX
@article{Xiang2024,
author = {Xiang, Weifang and Wang, Sirui and Pan, Ying and Cong, Xianling and Lu, Jun and Zhang, Yu},
title = {Cytoplasmic chromatin fragments: Divergent roles in senescence and cancer},
journal = {Ageing and Cancer Research & Treatment},
year = {2024},
doi = {10.70401/acrt.2026.0016}
}
EUVIMED